GO:0055010 ventricular cardiac muscle tissue morphogenesis: Chamber Wall Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055010 describes the biological process that generates and organizes the anatomical structures of ventricular cardiac muscle tissue.
• Ventricular morphogenesis involves spatially organized cellular communities, including cardiomyocytes, fibroblasts, endothelial cells and immune cells, that coordinate chamber wall thickening and trabeculation.
• Distinct molecular mechanisms regulate ventricular versus atrial chamber wall formation, with the RXRalpha gene acting non-cell-autonomously in ventricular muscle to control chamber morphogenesis.
• The neonatal mouse heart retains a transient regenerative capacity that depends on the coordinated morphogenesis of ventricular muscle tissue.
• Disruption of ventricular cardiac muscle tissue morphogenesis is linked to congenital heart defects, cardiomyopathy and conduction system abnormalities.
• Human heart organoids and spatially resolved single-cell atlases now enable researchers to study ventricular morphogenesis in vitro and in vivo.
Description
Ventricular cardiac muscle tissue morphogenesis (GO:0055010) is the developmental process that builds and organizes the muscular wall of the heart ventricles. This process is essential for establishing the thick, trabeculated ventricular myocardium that generates the contractile force required for systemic circulation. Researchers studying cardiac development rely on this Gene Ontology term to annotate genes and pathways that control ventricular chamber formation, from early cardiomyocyte differentiation to the spatial organization of distinct cell types within the ventricular wall. The importance of GO:0055010 extends beyond embryology: the neonatal mouse heart can transiently regenerate damaged ventricular muscle, and this regenerative window is tightly linked to the morphogenetic programs that build the ventricle in the first place. Understanding the molecular and cellular mechanisms of ventricular cardiac muscle tissue morphogenesis therefore has direct implications for congenital heart disease, cardiac regeneration and regenerative medicine. Recent advances in human heart organoids and spatially resolved single-cell atlases have begun to reveal how ventricular muscle tissue is assembled at unprecedented resolution, providing new opportunities to interrogate this process experimentally.
ventricular cardiac muscle tissue morphogenesis At A Glance
| GO ID | GO:0055010 |
|---|---|
| GO term | ventricular cardiac muscle tissue morphogenesis |
| Ontology | biological_process |
| Synonym | cardiac ventricle muscle morphogenesis; ventricular heart muscle morphogenesis |
| Definition | The process in which the anatomical structures of cardiac ventricle muscle is generated and organized. |
| Major function | Generation and spatial organization of ventricular myocardium during heart development |
| Related processes | Cardiac chamber morphogenesis, cardiomyocyte differentiation, trabeculation, compaction |
| Key cell types | Cardiomyocytes, fibroblasts, endothelial cells, immune cells |
| Research relevance | Congenital heart defects, cardiomyopathy, cardiac regeneration, conduction system development |
What Is GO:0055010?
According to the Gene Ontology, GO:0055010 (ventricular cardiac muscle tissue morphogenesis) is defined as the process in which the anatomical structures of cardiac ventricle muscle are generated and organized. In other words, it covers all developmental steps that produce the ventricular myocardium, including cardiomyocyte proliferation, differentiation, migration, trabeculation, compaction and the spatial arrangement of non-myocyte cell populations that together form functional ventricular muscle tissue. This term is a biological process and is distinct from atrial morphogenesis, as ventricular and atrial chamber walls form through partially distinct mechanisms.
Why Is ventricular cardiac muscle tissue morphogenesis Important in Cell Biology?
Ventricular cardiac muscle tissue morphogenesis is important because the ventricular wall is the primary pump of the heart, and defects in its formation cause severe congenital heart defects and contribute to cardiomyopathy and arrhythmia. The process also underlies the transient regenerative capacity of the neonatal heart, making it a central focus for cardiac regeneration research. Because ventricular and atrial chamber walls form through distinct mechanisms, understanding GO:0055010 specifically is essential for interpreting chamber-specific disease phenotypes and for designing targeted therapeutic strategies.
• Ventricular morphogenesis establishes the thick myocardial wall required for systemic circulation.
• Disruption of ventricular chamber formation causes congenital heart defects and conduction abnormalities.
• The neonatal mouse heart transiently regenerates ventricular muscle, linking morphogenesis to regeneration.
• Distinct ventricular versus atrial mechanisms mean chamber-specific pathways must be studied separately.
• Spatially organized cellular communities in the developing human heart are now mapped at single-cell resolution.
• Human heart organoids recapitulate early cardiac morphogenesis and axial organization in vitro.
• Laminin γ1 chain is essential for cardiorespiratory and muscular system development, including cardiac tissue.
• Cardiac lymphatic development is increasingly recognized as a component of normal heart biology.
• Dysregulation of ventricular morphogenesis is linked to cardiomyopathy and arrhythmia.
• Understanding GO:0055010 supports drug discovery and regenerative medicine for heart disease.
What Happens During ventricular cardiac muscle tissue morphogenesis?
Cardiomyocyte differentiation and early ventricular specification
In simple terms: Heart muscle cells first become specialized into ventricular-type cells.
Ventricular cardiac muscle tissue morphogenesis begins with the differentiation of cardiomyocytes that will form the ventricular wall. Spatially organized cellular communities in the developing human heart reveal that distinct cardiomyocyte subtypes emerge early and are spatially patterned within the ventricular region. The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development, indicating that nucleic acid structures and their regulators influence ventricular cell fate. Ventricular muscle-restricted targeting of RXRalpha demonstrates that non-cell-autonomous signaling from ventricular muscle is required for cardiac chamber morphogenesis.
Ventricular chamber wall formation and trabeculation
In simple terms: The ventricular wall thickens and forms ridges called trabeculae.
Once ventricular cardiomyocytes are specified, they proliferate and organize into a multilayered wall. Distinct mechanisms regulate ventricular and atrial chamber wall formation, with ventricular walls undergoing trabeculation and subsequent compaction. The laminin γ1 chain is essential for cardiorespiratory and muscular systems, and its absence disrupts cardiac tissue organization. Human heart organoids that elongate recapitulate early cardiac morphogenesis and axial organization, providing a model for ventricular wall formation.
Spatial organization of non-myocyte populations
In simple terms: Other cell types, such as fibroblasts and immune cells, arrange themselves around heart muscle cells.
Ventricular cardiac muscle tissue is not composed solely of cardiomyocytes. Spatially organized cellular communities form the developing human heart, with fibroblasts, endothelial cells and immune cells occupying distinct niches within the ventricular wall. Normal cardiac lymphatics and their mimics are also present in the heart and may influence ventricular tissue organization. These non-myocyte populations contribute to the structural and functional maturation of ventricular muscle tissue.
Ventricular conduction system development
In simple terms: The electrical wiring of the ventricle develops alongside the muscle.
Ventricular cardiac muscle tissue morphogenesis includes the development of the ventricular conduction system. Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development, linking morphogenetic programs to electrical function. Defects in ventricular morphogenesis can therefore manifest as conduction abnormalities and arrhythmia.
Regenerative potential and neonatal ventricular remodeling
In simple terms: Newborn hearts can briefly regrow ventricular muscle after injury.
The neonatal mouse heart has a transient regenerative potential that depends on the coordinated morphogenesis of ventricular muscle tissue. This regenerative window is characterized by cardiomyocyte proliferation and remodeling of the ventricular wall, processes that overlap with developmental morphogenesis. Understanding how ventricular morphogenesis is reactivated or suppressed after injury is a major goal of cardiac regeneration research.
Key Genes Involved in GO:0055010 ventricular cardiac muscle tissue morphogenesis
The following genes and proteins have been experimentally implicated in ventricular cardiac muscle tissue morphogenesis or closely related ventricular developmental processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RXRalpha | Non-cell-autonomous signaling in ventricular muscle for chamber morphogenesis | Ventricular muscle-restricted targeting reveals chamber morphogenesis defects |
| DHX36 | G4 resolvase modulating cardiomyocyte differentiation and ventricular conduction system development | Links nucleic acid structure regulation to ventricular morphogenesis |
| Laminin γ1 (LAMC1) | Extracellular matrix component essential for cardiorespiratory and muscular systems | Basement membrane integrity in ventricular tissue |
| Cardiomyocyte subtypes | Spatially organized cellular communities in the developing human heart | Single-cell atlas of ventricular morphogenesis |
| Fibroblasts | Contribute to ventricular wall structure and remodeling | Spatial organization in developing heart |
| Endothelial cells | Vascularize the ventricular myocardium | Cellular community organization in ventricle |
| Immune cells | Participate in ventricular tissue remodeling | Spatial atlas of developing heart |
| Conduction system cells | Form the ventricular electrical network | Dhx36-dependent development |
| Neonatal cardiomyocytes | Retain proliferative and regenerative capacity | Transient regeneration in mouse heart |
| Organoid cardiomyocytes | Recapitulate early cardiac morphogenesis in vitro | Elongating human heart organoids |
| Cardiac lymphatic endothelial cells | Form lymphatic vessels in the heart | Normal cardiac lymphatics and mimics |
| Atrial versus ventricular regulators | Distinct mechanisms for chamber wall formation | Chamber-specific morphogenesis |
| Extracellular matrix proteins | Provide structural support for ventricular tissue | Laminin γ1 and related components |
| Signaling pathway components | Regulate cardiomyocyte proliferation and differentiation | RXRalpha and related pathways |
| Transcription factors | Control ventricular gene expression programs | Chamber morphogenesis |
| G-quadruplex structures | Regulate gene expression in cardiomyocytes | Dhx36 target |
| Cardiac progenitor cells | Give rise to ventricular cardiomyocytes | Human heart development |
| Trabeculation regulators | Control ventricular wall ridge formation | Chamber wall formation |
How Is ventricular cardiac muscle tissue morphogenesis Regulated?
Ventricular cardiac muscle tissue morphogenesis is regulated by a combination of cell-intrinsic transcriptional programs and non-cell-autonomous signals. Ventricular muscle-restricted targeting of RXRalpha reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis, indicating that signaling from ventricular muscle influences neighboring tissues. The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development, suggesting that nucleic acid secondary structures and their regulators contribute to post-transcriptional control of ventricular morphogenesis. Distinct mechanisms regulate ventricular and atrial chamber wall formation, implying chamber-specific regulatory networks. Spatially organized cellular communities in the developing human heart further indicate that local microenvironmental signals shape ventricular tissue organization. The neonatal regenerative response also involves regulated cardiomyocyte proliferation and remodeling, which are under developmental control.
ventricular cardiac muscle tissue morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RXRalpha | Congenital heart defects, chamber morphogenesis failure | Ventricular muscle-restricted knockout mouse |
| DHX36 | Ventricular conduction system abnormalities | Cardiomyocyte-specific knockout or point mutation |
| Laminin γ1 (LAMC1) | Cardiorespiratory and muscular system defects | Conditional knockout mouse |
| Cardiomyocyte subtypes | Congenital heart disease, regeneration failure | Human heart organoids and single-cell atlas |
| Cardiac lymphatics | Lymphatic and cardiac homeostatic disorders | Lymphatic endothelial cell models |
Congenital heart defects
Disruption of ventricular cardiac muscle tissue morphogenesis causes congenital heart defects, including ventricular septal defects and hypoplastic ventricle phenotypes. Ventricular muscle-restricted targeting of RXRalpha reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis, and its loss leads to severe chamber malformations. Distinct mechanisms regulate ventricular and atrial chamber wall formation, and perturbations in these pathways can produce chamber-specific defects.
Cardiomyopathy and conduction disorders
Abnormal ventricular morphogenesis is linked to cardiomyopathy and conduction system disease. Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development, and its dysfunction is associated with ventricular conduction abnormalities. Laminin γ1 chain is essential for the cardiorespiratory and muscular systems, and its deficiency causes cardiac and muscular pathology.
Cardiac regeneration failure
The neonatal mouse heart has a transient regenerative potential, but this capacity is lost in adults, contributing to heart failure after myocardial infarction. Understanding the morphogenetic programs that support neonatal regeneration may inform strategies to reactivate them in adult hearts.
Lymphatic and vascular contributions
Normal cardiac lymphatics and their mimics are increasingly recognized as important for heart homeostasis, and their disruption may contribute to ventricular pathology. Vascular and lymphatic components are integral to the cellular communities that form the developing heart.
From ventricular cardiac muscle tissue morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for ventricular chamber morphogenesis? | Ventricular muscle-restricted knockout mouse |
| Does a point mutation in a candidate gene cause conduction defects? | Point-mutation knock-in mouse or human iPSC-derived cardiomyocytes |
| Can a human variant be modeled in vitro? | Human heart organoids with CRISPR knock-in |
| What is the spatial organization of ventricular cell types? | Spatially resolved single-cell atlas |
| Can neonatal regeneration be recapitulated? | Neonatal mouse heart injury model |
| Is a gene required for cardiac lymphatic development? | Lymphatic endothelial-specific knockout |
How to Study the ventricular cardiac muscle tissue morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomes of individual ventricular cells | Cell type diversity in developing heart |
| Spatial transcriptomics | Gene expression with spatial context | Cellular community organization in ventricle |
| Human heart organoids | In vitro cardiac morphogenesis | Modeling ventricular development and disease |
| Conditional knockout | Gene function in specific cell lineages | Ventricular muscle-restricted targeting |
| Lineage tracing | Cell fate and migration | Cardiomyocyte origins in ventricle |
| Neonatal injury assay | Regenerative capacity | Transient regeneration in mouse heart |
| Immunohistochemistry | Protein localization in tissue | Ventricular wall structure |
| Electrophysiology | Conduction properties | Ventricular conduction system development |
Spatially resolved single-cell transcriptomics
Spatially organized cellular communities in the developing human heart have been mapped using single-cell and spatial transcriptomics, revealing how cardiomyocytes, fibroblasts, endothelial cells and immune cells are arranged within the ventricular wall. This method is essential for understanding the cellular composition of ventricular cardiac muscle tissue morphogenesis.
Human heart organoid models
Elongating human heart organoids recapitulate early cardiac morphogenesis and axial organization, providing a tractable in vitro system to study ventricular morphogenesis and to test gene function. Organoids can be combined with CRISPR editing to interrogate candidate genes.
Genetic lineage tracing and conditional knockout
Ventricular muscle-restricted targeting of RXRalpha using conditional knockout approaches revealed a non-cell-autonomous requirement in cardiac chamber morphogenesis. Lineage tracing and conditional alleles allow precise temporal and spatial control of gene function.
Neonatal regeneration assays
The neonatal mouse heart transiently regenerates after injury, and this assay is used to study the regenerative potential of ventricular muscle tissue. Combining this model with genetic perturbations can identify regulators of morphogenesis and regeneration.
How CRISPR Can Be Used to Study GO:0055010 ventricular cardiac muscle tissue morphogenesis
Knockout
CRISPR knockout of candidate genes in cardiomyocytes or model organisms can test their requirement for ventricular cardiac muscle tissue morphogenesis. For example, ventricular muscle-restricted targeting of RXRalpha revealed a non-cell-autonomous requirement in chamber morphogenesis. Knockout models are essential for establishing causality.
Point Mutation
CRISPR point mutation can model human variants associated with congenital heart defects or conduction disorders. Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development, and point mutations in such genes can be introduced to study their effects on ventricular morphogenesis.
Knock-in
Knock-in of reporter or tagged alleles allows visualization and tracking of specific cell populations during ventricular morphogenesis. Spatially organized cellular communities in the developing human heart have been studied using such approaches. Knock-in of human variants into iPSCs or organoids can model disease.
Overexpression
CRISPR overexpression or activation can test whether increased dosage of a candidate gene enhances or disrupts ventricular morphogenesis. Overexpression of signaling components such as RXRalpha pathway members may alter chamber morphogenesis. This approach complements loss-of-function studies.
How EDITGENE Supports ventricular cardiac muscle tissue morphogenesis Research
Researchers studying ventricular cardiac muscle tissue morphogenesis-related genes often need to determine whether a candidate gene is causally involved in ventricular chamber formation, conduction system development or regeneration. EDITGENE provides CRISPR-based cell models and screening services to interrogate these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for ventricular cardiac muscle tissue morphogenesis research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SMAD7 Knockout HEK293 Cell Line | EDJ-KQ403 | Human | 4092 | Details Get a Quote |
| TNNT2 Knockout HEK293 Cell Line | EDJ-KQ939 | Human | 7139 | Details Get a Quote |
| MYL2 Knockout HEK293 Cell Line | EDJ-KQ1438 | Human | 4633 | Details Get a Quote |
| MYL3 Knockout HEK293 Cell Line | EDJ-KQ1439 | Human | 4634 | Details Get a Quote |
| TNNC1 Knockout HEK293 Cell Line | EDJ-KQ1632 | Human | 7134 | Details Get a Quote |
| TNNI3 Knockout HEK293 Cell Line | EDJ-KQ1813 | Human | 7137 | Details Get a Quote |
| MYH7 Knockout HEK293 Cell Line | EDJ-KQ1837 | Human | 4625 | Details Get a Quote |
| MYH6 Knockout HEK293 Cell Line | EDJ-KQ1838 | Human | 4624 | Details Get a Quote |
| TGFBR3 Knockout HEK293 Cell Line | EDJ-KQ2915 | Human | 7049 | Details Get a Quote |
| PROX1 Knockout HEK293 Cell Line | EDJ-KQ3353 | Human | 5629 | Details Get a Quote |
| ISL1 Knockout HEK293 Cell Line | EDJ-KQ5008 | Human | 3670 | Details Get a Quote |
| MYBPC3 Knockout HEK293 Cell Line | EDJ-KQ5279 | Human | 4607 | Details Get a Quote |
| PKP2 Knockout HEK293 Cell Line | EDJ-KQ5473 | Human | 5318 | Details Get a Quote |
| TPM1 Knockout HEK293 Cell Line | EDJ-KQ5956 | Human | 7168 | Details Get a Quote |
| HAND1 Knockout HEK293 Cell Line | EDJ-KQ6583 | Human | 9421 | Details Get a Quote |
Displaying Records 1 To 15 Of 78 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About ventricular cardiac muscle tissue morphogenesis
What is GO:0055010?
GO:0055010 is the Gene Ontology term for ventricular cardiac muscle tissue morphogenesis, the process in which the anatomical structures of cardiac ventricle muscle are generated and organized.
What genes are involved in ventricular cardiac muscle tissue morphogenesis?
Genes such as RXRalpha, DHX36 and LAMC1 have been implicated in ventricular chamber morphogenesis, cardiomyocyte differentiation and cardiac tissue organization.
Why is ventricular cardiac muscle tissue morphogenesis important?
It is essential for forming the thick ventricular wall required for systemic circulation, and its disruption causes congenital heart defects and conduction disorders.
How is ventricular morphogenesis studied?
Researchers use single-cell and spatial transcriptomics, human heart organoids, conditional knockout mice and neonatal regeneration assays.
What is the difference between ventricular and atrial chamber wall formation?
Distinct mechanisms regulate ventricular and atrial chamber wall formation, meaning chamber-specific pathways must be studied separately.
Can the neonatal heart regenerate ventricular muscle?
The neonatal mouse heart has a transient regenerative potential that depends on coordinated ventricular muscle morphogenesis.
What role does DHX36 play in ventricular development?
DHX36 is a G4 resolvase that modulates cardiomyocyte differentiation and ventricular conduction system development.
What is the role of RXRalpha in cardiac chamber morphogenesis?
Ventricular muscle-restricted targeting of RXRalpha reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis.
Are there human heart organoid models for ventricular morphogenesis?
Yes, elongating human heart organoids recapitulate early cardiac morphogenesis and axial organization.
How can CRISPR help study ventricular cardiac muscle tissue morphogenesis?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of candidate genes in cardiomyocytes and organoids.
Conclusion
Ventricular cardiac muscle tissue morphogenesis (GO:0055010) is a fundamental developmental process that builds the ventricular myocardium through coordinated cardiomyocyte differentiation, chamber wall formation, spatial organization of non-myocyte populations and conduction system development. Its disruption causes congenital heart defects and contributes to cardiomyopathy and regeneration failure. Advances in human heart organoids, spatial transcriptomics and CRISPR modeling now provide powerful tools to dissect this process and to identify therapeutic targets.
References
- 1. Farah EN et al.. 2024. Spatially organized cellular communities form the developing human heart.. Nature 627(8005):854-864 PMID: 38480880
- 2. Porrello ER et al.. 2011. Transient regenerative potential of the neonatal mouse heart.. Science 331(6020):1078-80 PMID: 21350179
- 3. Albu M et al.. 2024. Distinct mechanisms regulate ventricular and atrial chamber wall formation.. Nat Commun 15(1):8159 PMID: 39289341
- 4. Gómez-Del Arco P et al.. 2024. The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development.. Nat Commun 15(1):8602 PMID: 39366945
- 5. Lee J et al.. 2026. Elongating human heart organoids recapitulate early cardiac morphogenesis and axial organization.. Dev Cell 61(9):1898-1914.e7 PMID: 42580346
- 6. Chen J et al.. 1998. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis.. Development 125(10):1943-9 PMID: 9550726
- 7. Gawlik KI et al.. 2025. Laminin γ1 chain is essential for the cardiorespiratory and muscular systems.. Matrix Biol 141:47-66 PMID: 40854378
- 8. Ware SA et al.. 2026. Normal cardiac lymphatics and their mimics.. Am J Physiol Heart Circ Physiol 330(1):H170-H186 PMID: 41285409
